Insights

Growth footprint REV Clinical operates as a US-based global clinical CRO with a growing international footprint, offering speed and capital-efficient execution from first-in-human to late-phase studies. This expansion potential suggests sales opportunities in new regional markets and cross-border trial capabilities for sponsors seeking agile, scalable CRO support.

Strategic partnerships Recent collaboration activity includes a strategic partnership with NeOnc Technologies Holdings, signaling a receptiveness to alliances that enhance trial pipelines. This indicates opportunities to pursue co-development or multi-phase trial programs with oncology-focused or biotech sponsors looking for integrated CRO support.

Industry engagement Active participation in major events such as AACR 2025 and ISCR Annual Conference with Silver Sponsor status demonstrates visibility among cancer research and clinical trial professionals. Sales teams can leverage this positioning to initiate conversations with potential sponsors attending these events or seeking CRO partners with oncology expertise.

Lean, tech-enabled A technology-forward profile with a cloud-based stack and digital engagement tools suggests the ability to deliver efficient, transparent study management. This can be highlighted to potential clients prioritizing streamlined operations, data access, and cost-effective trial execution.

Mid-market focus Revenue range and employee size place REV Clinical in the mid-market CRO segment, aligning with small to mid-sized sponsors across multiple therapeutic areas. This presents clear opportunities to target biotech startups and mid-stage sponsors seeking reliable, flexible partners without large-tier CRO commitments.

Similar companies to REV Clinical, Previously CBCC Global Research

REV Clinical, Previously CBCC Global Research Tech Stack

REV Clinical, Previously CBCC Global Research uses 8 technology products and services including Linkedin Insight Tag, Amazon Web Services, WordPress, and more. Explore REV Clinical, Previously CBCC Global Research's tech stack below.

Linkedin Insight Tag
Analytics
Amazon Web Services
Cloud Hosting
WordPress
Content Management System
CookieYes
Cookie Compliance
Salesforce
Customer Relationship Management
Mailgun
Email
HubSpot
Marketing Automation
WP Engine
Platform As A Service

Media & News

REV Clinical, Previously CBCC Global Research's Email Address Formats

REV Clinical, Previously CBCC Global Research uses at least 2 format(s):

REV Clinical, Previously CBCC Global Research Email Formats	Example	Percentage
First.Last@cbcc.global	John.Doe@cbcc.global	99%
First.L@cbcc.global	John.D@cbcc.global	1%
First.Last@revclinical.com	John.Doe@revclinical.com	100%

Frequently Asked Questions

What is REV Clinical, Previously CBCC Global Research's phone number?

You can contact REV Clinical, Previously CBCC Global Research's main corporate office by phone at

+1-661-322-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is REV Clinical, Previously CBCC Global Research's official website and social media links?

REV Clinical, Previously CBCC Global Research's official website is revclinical.com and has social profiles on LinkedIn.

How much revenue does REV Clinical, Previously CBCC Global Research generate?

As of July 2026, REV Clinical, Previously CBCC Global Research's annual revenue is estimated to be $1M - $10M.

What is REV Clinical, Previously CBCC Global Research's NAICS code?

REV Clinical, Previously CBCC Global Research's NAICS code is 5417 - Scientific Research and Development Services.

How many employees does REV Clinical, Previously CBCC Global Research have currently?

As of July 2026, REV Clinical, Previously CBCC Global Research has approximately 228 employees across 5 continents, including AsiaNorth AmericaSouth America. Key team members include Ceo: A. A.Senior Vice President - India Operations: S. S.Director, Data Management And Bio-Statistics: N. P.. Explore REV Clinical, Previously CBCC Global Research's employee directory with LeadIQ.

What industry does REV Clinical, Previously CBCC Global Research belong to?

REV Clinical, Previously CBCC Global Research operates in the Research Services industry.

What technology does REV Clinical, Previously CBCC Global Research use?

REV Clinical, Previously CBCC Global Research's tech stack includes Linkedin Insight TagAmazon Web ServicesWordPressCookieYesSalesforceMailgunHubSpotWP Engine.

What is REV Clinical, Previously CBCC Global Research's email format?

REV Clinical, Previously CBCC Global Research's email format typically follows the pattern of First.Last@cbcc.global. Find more REV Clinical, Previously CBCC Global Research email formats with LeadIQ.

When was REV Clinical, Previously CBCC Global Research founded?

REV Clinical, Previously CBCC Global Research was founded in 2010.

REV Clinical, Previously CBCC Global Research

Research ServicesCalifornia, United States201-500 Employees

REV Clinical is a US-based global contract research organization that provides clinical development services to sponsors across multiple therapeutic areas. The company works with small and mid-sized sponsors to conduct studies from first-in-human through late-phase development, prioritizing speed, flexibility, and capital-efficient execution. Its teams operate as an extension of client groups, emphasizing transparent, reliable collaboration to move studies forward. The organization traces its history to CBCC Global Research, continuing the work under the REV Clinical name. Based in Bakersfield, California, REV Clinical sits within the research services industry and is expanding its international footprint to serve a global client base. A March 2025 partnership with NeOnc Technologies Holdings is among the recent developments connected to CBCC Global Research.